Close

Ratings by BMO Capital (Evan David Seigerman)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/28/2022 Biogen BIIB Upgrade Outperform
(Market Perform)
195.75
(258.26)
31.93% Details
9/22/2022 Pfizer PFE Maintain Outperform
(N/A)
 
 
  Details
9/12/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
9/8/2022 Regeneron Pharma REGN Maintain Outperform
(N/A)
 
 
  Details
9/6/2022 Eli Lilly LLY Maintain Outperform
(N/A)
 
 
  Details
8/3/2022 Gilead Sciences GILD Maintain Market Perform
(Market Perform)
 
 
  Details
8/2/2022 Incyte INCY Maintain Market Perform
(Market Perform)
 
 
  Details
7/20/2022 Biogen BIIB Maintain Market Perform
(Market Perform)
 
 
  Details
7/19/2022 Incyte INCY Maintain Market Perform
(Market Perform)
 
 
  Details
7/11/2022 Vertex VRTX Maintain Outperform
(Outperform)
 
 
  Details
7/5/2022 Vertex VRTX Maintain Outperform
(Outperform)
 
 
  Details
6/24/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
6/7/2022 Mirati Therapeutics MRTX Maintain Outperform
(Outperform)
 
 
  Details
6/6/2022 Gilead Sciences GILD Maintain Market Perform
(Market Perform)
 
 
  Details
5/6/2022 Eli Lilly LLY Maintain Outperform
(N/A)
 
 
  Details
5/4/2022 Neurocrine Bio. NBIX Maintain Underperform
(Underperform)
 
 
  Details
5/4/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
5/3/2022 Biogen BIIB Maintain Market Perform
(Market Perform)
 
 
  Details
5/2/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
4/29/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(Outperform)
 
 
  Details
4/28/2022 Gilead Sciences GILD Maintain Market Perform
(Market Perform)
 
 
  Details
4/28/2022 Eli Lilly LLY Maintain Outperform
(Outperform)
 
 
  Details
4/27/2022 Amgen AMGN Maintain Market Perform
(Market Perform)
 
 
  Details
4/19/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
4/7/2022 Pfizer PFE Maintain Outperform
(Outperform)
 
 
  Details
4/5/2022 Merck MRK Maintain Outperform
(Outperform)
 
 
  Details
3/31/2022 Candel Therapeutics Inc. CADL Maintain Outperform
(N/A)
 
 
  Details
3/30/2022 Amgen AMGN Maintain Market Perform
(Market Perform)
 
 
  Details
3/30/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
3/29/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
3/23/2022 Pfizer PFE Maintain Outperform
(Outperform)
 
 
  Details
3/22/2022 Vertex VRTX Maintain Outperform
(Outperform)
 
 
  Details
3/15/2022 Biogen BIIB Maintain Outperform
(Outperform)
 
 
  Details
3/14/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(Outperform)
 
 
  Details
3/7/2022 Biogen BIIB Maintain Market Perform
(Market Perform)
 
 
  Details
3/7/2022 Gilead Sciences GILD Maintain Market Perform
(Market Perform)
 
 
  Details
3/4/2022 Gilead Sciences GILD Maintain Market Perform
(Market Perform)
 
 
  Details
3/1/2022 Pfizer PFE Maintain Outperform
(Outperform)
 
 
  Details
3/1/2022 Mirati Therapeutics MRTX Maintain Outperform
(Outperform)
 
 
  Details
2/28/2022 Gilead Sciences GILD Downgrade Market Perform
(Outperform)
60.61
(64.25)
6.01% Details
2/16/2022 Biogen BIIB Maintain Market Perform
(Market Perform)
 
 
  Details
2/16/2022 Gilead Sciences GILD Maintain Outperform
(Outperform)
 
 
  Details
2/15/2022 Amgen AMGN Maintain Market Perform
(Market Perform)
 
 
  Details
2/14/2022 Neurocrine Bio. NBIX Maintain Underperform
(N/A)
 
 
  Details
2/11/2022 Neurocrine Bio. NBIX Maintain Underperform
(Underperform)
 
 
  Details
2/11/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
2/11/2022 Neurocrine Bio. NBIX Maintain Outperform
(Outperform)
 
 
  Details
2/8/2022 Amgen AMGN Maintain Market Perform
(Market Perform)
 
 
  Details
2/8/2022 Incyte INCY Maintain Market Perform
(Market Perform)
 
 
  Details
2/8/2022 Pfizer PFE Maintain Outperform
(Outperform)
 
 
  Details
2/7/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
2/4/2022 Regeneron Pharma REGN Maintain Outperform
(Outperform)
 
 
  Details
2/4/2022 Bristol-Myers Squibb Co. BMY Maintain Outperform
(Outperform)
 
 
  Details
2/4/2022 Eli Lilly LLY Maintain Outperform
(N/A)
 
 
  Details
2/4/2022 Biogen BIIB Downgrade Market Perform
(Outperform)
220.17
(258.26)
17.3% Details
2/3/2022 Biogen BIIB Maintain Outperform
(Outperform)
 
 
  Details
2/3/2022 Merck MRK Maintain Market Perform
(Market Perform)
 
 
  Details
2/3/2022 Eli Lilly LLY Maintain Outperform
(Outperform)
 
 
  Details
2/2/2022 Gilead Sciences GILD Maintain Outperform
(Outperform)
 
 
  Details
1/26/2022 Vertex VRTX Maintain Outperform
(Outperform)
 
 
  Details
1/20/2022 Vertex VRTX Upgrade Outperform
(Market Perform)
231.07
(294.14)
27.29% Details
1/14/2022 Pfizer PFE Maintain Outperform
(Outperform)
 
 
  Details
1/13/2022 Gilead Sciences GILD Maintain Outperform
(Outperform)
 
 
  Details
1/13/2022 Biogen BIIB Maintain Outperform
(N/A)
 
 
  Details
12/16/2021 Eli Lilly LLY Maintain Outperform
(N/A)
 
 
  Details
11/19/2021 Neurocrine Bio. NBIX New Coverage Underperform
(N/A)
89.60
(108.48)
21.07% Details
11/19/2021 Vertex VRTX New Coverage Market Perform
(N/A)
188.25
(294.14)
56.25% Details
11/19/2021 Merck MRK New Coverage Market Perform
(N/A)
82.60
(87.68)
6.15% Details
11/19/2021 Incyte INCY New Coverage Market Perform
(N/A)
65.02
(68.49)
5.34% Details
11/19/2021 Amgen AMGN New Coverage Market Perform
(N/A)
205.82
(229.50)
11.51% Details
11/19/2021 Regeneron Pharma REGN New Coverage Outperform
(N/A)
641.83
(722.94)
12.64% Details
11/19/2021 Pfizer PFE New Coverage Outperform
(N/A)
50.87
(42.19)
-17.06% Details
11/19/2021 Mirati Therapeutics MRTX New Coverage Outperform
(N/A)
138.50
(67.38)
-51.35% Details
11/19/2021 Eli Lilly LLY New Coverage Outperform
(N/A)
261.18
(325.99)
24.81% Details
11/19/2021 Candel Therapeutics Inc. CADL New Coverage Outperform
(N/A)
10.60
(3.03)
-71.42% Details
11/19/2021 Gilead Sciences GILD New Coverage Outperform
(N/A)
67.46
(64.25)
-4.76% Details
11/19/2021 Bristol-Myers Squibb Co. BMY New Coverage Outperform
(N/A)
59.44
(69.63)
17.14% Details
11/19/2021 Biogen BIIB New Coverage Outperform
(N/A)
258.38
(258.26)
-0.05% Details